Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may cause depression, affecting sleep and relationships.

Adding human hair to clayey soil makes it stronger, even after freeze-thaw cycles, and is eco-friendly and cheap.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

More research is needed to understand sex and racial differences in long COVID.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Glehnia littoralis and Andrographis paniculata extracts can significantly boost hair growth.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Hair loss in twins may be linked to family history of hair loss, high blood pressure, heart disease, and possibly anxiety, but more research is needed.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Post-COVID syndrome causes long-lasting symptoms like fatigue, breathing issues, and anxiety.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Long COVID causes various long-term health issues and needs better awareness and treatment.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.